Physician profile
Mariah Wagner
NPI 1407329246
$869.03
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $442 · 2023: $288 · 2024: $16.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.24 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $255.36 | 2021-2024 | |
| Lilly USA, LLC | $153.83 | 2021-2023 | Mounjaro, Trulicity |
| Astellas Pharma US INC | $82.16 | 2023 | Myrbetriq |
| Novartis Pharmaceuticals Corporation | $67.09 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $59.82 | 2022-2023 | Abilify Maintena |
| Amgen INC. | $51.92 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $48.83 | 2022 | |
| Nestle Healthcare Nutrition INC. | $46.77 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $28.85 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.40 | 2021-2022 | |
| Axsome Therapeutics, INC. | $19.39 | 2023 | Auvelity |
| Novo Nordisk INC | $14.45 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariah Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.